Tuesday 22 May 2012

Pharmacy Daily Tuesday 22nd May 2012 T 1300 799 220 W www.pharmacydaily.com.au page 1

“Boost Your Financial Management”At Joondalup Resort

PERTH 6-8th June 2012 WA

Essential skills you need for profit & growth.

Over 2,000 pharmacists have attended.

CLICK HERE to go to brochure.

Accredited for 54 Group 2 CPD points

“The most practical, demystifying course I

have been to” - Megan Kelly, Kiama

Cheaper Tuesday TODAY’S Pharmacy Dailyfeatures two pages full of news,plus a full page from ReformManagement which details itsCheaper Tuesday deals, includingMaxiclear Cold & Flu Relief 24tablets at $2.20 each- see p3 fordetails.

Pharmacists on the Board QUEENSLAND pharmacists ScottMcCahon from Weipa on the CapeYork Peninsula and Terry Whitefrom Brisbane have been appointedas Chairs of their local Health andHospital Boards. The appointments are part of theQueensland Government’sreintroduction of local HealthBoards, with Queensland HealthMinister, Lawrence Springborgsaying that each Board wouldrequire a highly-skilled leader in itslocal community to serve as itsChair. Scott McCahon comes to theposition as the owner of the 2012Pharmacy of the Year, which overthe years has become an integralpart of the Weipa community;whilst Terry White is the Chairmanof White Retail and Terry WhiteChemists and the foundingChairman of the Nudgee CollegeFoundation. White has also served as aMember of Parliament, Minister ofthe Crown and President of thePharmacy Guild. As a result of their latestappointments, Scott McCahon willnow take up the role as Chair of theCape York Hospital and HealthBoard whilst Terry White is tobecome the Chair of the MetroSouth Board. Pharmaceutical Society ofAustralia Queensland Branch

President, Dr Lisa Nissen, haswelcomed the new appointmentssaying “This is a strongendorsement for the active andsubstantial contribution pharmacistsaround Queensland and Australiamake on a daily basis to not onlythe care of their patients but alsoto the broader communities inwhich they work and live”. “There is no doubt that bothTerry and Scott bring exceptionalskill and commitment to health-care, communities and pharmacyto these roles and are amazing rolemodels for the profession and forothers engaged in the hospital andhealth boards. “The Queensland pharmacycommunity are certainly very proudof both of them,” she added.

Obese freight train LEADING nutritional expert, DrJohn Berardi has warned thatobesity and diabetes are “likefreight trains running out ofcontrol”. "Of course, that's not a fitnessindustry thing,” he said. “Instead, it has everything to dowith the combination of sedentarylabor, few natural opportunities forexercise and movement, hugeaccess to high calorie, processedfoods, and a tremendous amountof personal stress,” he added. Speaking to reporters in the wakeof a recent fitness convention heldin the UK, Berardi said that ratherthan just being an issue ofwillpower, and telling people to eatless and exercise more, the solutionis “about reaching people wherethey are at”. “It's only when we're willing toreach out beyond fitness club wallsand engage people at home, intheir workplaces, and in the otherplaces they spend time, that we'llreally have the impact we hope to,”he said.

Auxilium expects better PHARMACEUTICAL companyAuxilium has raised its full year2012 revenue guidance to a rangeof US$293 million to US$315 million. The company has also reduced itsguidance for net loss to a range ofUS$5 million to US$10 million.

Prostate test warnings THE Prostate Cancer Foundationof Australia (PCFA) has respondedto a recent US Preventive ServicesTask Force recommendation whichadvises against Prostate SpecificAntigen (PSA) based prostatecancer screening in men of all ageranges, saying it is “unhelpful andnot based on a correctinterpretation of the variousrandomised control trials that havelooked into the benefits of PSAtesting”. “PCFA recommends that menover the age of 50 years – or 40years with a family history – speakto their doctor about their individualprostate cancer risk and testingoptions,” the organisation said. www.healthpointtech.com

Interactive advice and screening tools now available

for your Pharmacy

Call 1300 367 611

healthpoint

Go back Print Quiz LogoutGo Go backback PP QQPrintPrint LogoutQuizQuiz

healthpoint

Tuesday 22 May 2012

EDITORS Bruce Piper and Amanda Collins EMAIL info@pharmacydaily.com.au ADVERTISING Magda Herdzik EMAIL advertising@pharmacydaily.com.au page 2

Weekly CommentWeekly Comment

Guild Update

QCPPCommunications

Survey The Quality Care PharmacyProgram (QCPP) beganconducting a Guild-approvedsurvey yesterday, with the aimof finding out what QCPP-accredited pharmacies think ofthe program’s communicationmaterials. This information will be usedto assist in the development offuture communicationmaterials and determine howthey will be provided topharmacies. This information will enableQCPP to provide accreditedpharmacies with theinformation they want, theway they want it. Independent research firm,Colmar Brunton, has beencommissioned to undertakethis important study. Over the next month, arepresentative from ColmarBrunton will contact QCPPaccredited pharmacies toinvite them to participate inthe study by way of an onlineor telephone survey. The survey will take around10 minutes to complete. All feedback will be treated inthe strictest of confidence, andno individuals will be identifiedin the final report ColmarBrunton produces. Pharmacies are encouragedto make time available and tocontribute to the study. If you have any queries inrelation to the project, pleasedon’t hesitate to contact theQCPP helpline on 1300 363 340or via email athelp@qcpp.com.

PSA All you need for your CPD.Register atwww.psa.org.au/education/conferences/cpexpo

Clinical and Practice Expo 2012HORDERN PAVILION, DRIVER AVENUE, MOORE PARK, SYDNEY

25–27 May 2012Connecting practice to patient outcomes

2012

CPExpo

34GROUP 2

UP

TO

CPD CREDITS

Antidepressants needed? NON-drug therapies should beused as first line for milddepression, and in combinationwith antidepressants for moresevere depression, according toNPS. The comments come on the backof the release of NPS’ latesttherapeutic program Depression:Challenges in primary care, whichencourages healthcare providers tocarefully assess the severity ofdepressive symptoms in patientsdiagnosed with major depressivedisorder and then considerwhether an antidepressant isnecessary. “When determining if a patientcould benefit from taking anantidepressant, a globalassessment of the severity of theirsymptoms should be made, withparticular consideration of thedegree to which their day to dayfunctioning is impaired andwhether they have had suicidalthoughts or intent,” said NPSclinical adviser Dr DanielleStowasser. In addition, the NPS said thathealthcare practitioners who arelooking to use antidepressants intreating their patients, shouldconsider the patient’s previousexperience with antidepressants,along with potential druginteractions and the likelihood ofadverse events, such as weightgain, sexual dysfunction andgastrointestinal upset. “It is particularly important toassess the balance of benefits andharms in older patients, since theyexperience adverse effects anddrug interactions more frequentlythan younger patients,” Stowassersaid. According to NPS, between one-third and one-half of patientsprescribed an antidepressantdiscontinue within three months ofstarting treatment. The major factors contributing tothese discontinuations include: sideeffects, and a lack of understandingof depression as a condition andwhat to expect from treatment. To remedy this, NPS suggests thathealthcare professionals discuss

issues related to antidepressanttherapy with their patientsincluding: potential side effects,how long before the full benefit oftreatment is likely to beexperienced, likely duration oftreatment, dangers ofnon-adherence and of stoppingtreatment abruptly, concerns aboutaddiction, and interactions withover-the-counter medicines such asSt John’s Wort and many cough andcold medicines. For more information see-www.nps.org.au/conditions/depression.

Sleep apnea and cancer A NEW study has found thatsleep apnea is associated with anincreased risk of cancer mortality. Set to be published in theAmerican Journal of Respiratoryand Critical Care Medicine, thestudy looked at 22-year mortalitydata on 1,522 people who wereenrolled in the Wisconsin SleepCohort study. The participants in the studyunderwent overnight sleep studiesthat included all-night recording ofsleep and breathing, as well asother tests at four-year intervals. According to the study findings,people with severe sleep apneawere 4.8 times more likely to diefrom cancer. “Clearly, there is a correlation,and we are a long way fromproving that sleep apnea causescancer or contributes to itsgrowth,” said study author DrJavier Nieto, Chair of theDepartment of Population HealthSciences at the University ofWisconsin-Madison. “But animal studies have shownthat the intermittent hypoxia (aninadequate supply of oxygen) thatcharacterises sleep apneapromotes angiogenesis—increasedvascular growth—and tumorgrowth,” he added, referring to aa separate study from researchersat the University of Barcelona,which found that inadequatelevels of oxygen may increase thegrowth of tumours in mice.

ALCOHOL and driving don’t mix. A truck packed to the brim withbeer wreaked havoc on Polishtraffic when its load spilled outover a busy roundabout. The truck driver caused thedebacle after trying to turn in theroundabout to quickly. The resulting traffic chaoscaused the closure of the wholeroad, and left firefighters with thefive hour job of picking up bottlesand hosing away beer.

Every day this weekPD is giving 3 luckyreaders the chanceto win a Summer’s

Eveexclusivegift,valuedat $14.00.

All Summer’s Eve products aredermatologist andgynaecologist tested forgentleness and effectiveness.They are also part of thesensitive range meaning theyare alcohol free andhypoallergenic.

To win, simply be one of thefirst three people to send in thecorrect answer to the questionbelow to:comp@pharmacydaily.com.au

WIN SUMMER’SWIN SUMMER’SWIN SUMMER’SWIN SUMMER’SWIN SUMMER’SEVE PRIZE PACKEVE PRIZE PACKEVE PRIZE PACKEVE PRIZE PACKEVE PRIZE PACK

Hint! Visitwww.keysun.com.au

What does being part ofWhat does being part ofWhat does being part ofWhat does being part ofWhat does being part ofthe Sensitive Range forthe Sensitive Range forthe Sensitive Range forthe Sensitive Range forthe Sensitive Range forSummer’s Eve mean forSummer’s Eve mean forSummer’s Eve mean forSummer’s Eve mean forSummer’s Eve mean for

these products?these products?these products?these products?these products?

Order

Fax order to

(02) 8569 1886

This Cheaper Tuesday sale ends 5pm 25th May 2012

Order

Plus 1 on 12

Maxiclear Cold & Flu Relief. 24 Tablets

$2.20 each Excl. GST Minimum 12 units

Maxiclear Sinus & Pain Relief. 24Tablets

$2.20 each Excl. GST Minimum 12 units Plus 1 on 12

Pharmacy Name:

Address :

Suburb : State :

Phone : Wholesaler:

Wholesaler Acct Number :

Phenylephrine Hydrochloride 5mg & Paracetamol 500mg

Phenylephrine Hydrochloride 5mg & Paracetamol 500mg